MMS

We’re excited to announce that MMS will be exhibiting at the world-renowned Society for Clinical Data Management (SCDM) Annual Conference in Boston next month! This year’s conference, aptly titled “The Festival of Opportunity,” is packed with cutting-edge technology, world-class speakers, and key presentations on topics ranging from CDS and analytics to AI and cognitive tech. While you’re there, visit our booth #313 to: ✅ Discover new insights by engaging with our experts and learning about the latest advancements in clinical data management ✅ Explore powerful technology and see how our solutions can drive data integrity and increase patient safety ✅ Network with peers, meet new friends, and connect with industry leaders from around the globe Let’s explore how we can shape the future of pharma together. Register now and message us to set a meeting: https://hubs.li/Q02MH4Vy0 #SCDM24

We recently posted a new blog article titled "Validation of Clinical Dashboards for Decision Making!" From our perspective, validation is the key to ensuring that clinical dashboard standards are upheld. By following the 3 steps outlined in this article, we can minimize oversight and prevent misrepresentation within clinical dashboards. Read our insights here: https://hubs.li/Q02MvT1X0 #DataScience #PowerBI #ClinicalData

Today marks the beginning of our highly anticipated PHUSE Single Day Event (SDE) in Bloemfontein, South Africa – The Efficiency Journey: Digital Transformation, Automation, and Open Source! SDE Chairs Pieter Cloete and Landró Van der Walt are kicking off today’s event, setting the stage for an exciting day filled with innovation and insights! 📊 Presentations to watch: ✔️ Vangeli Grammatikos and Burger Lubbe: Saying Please to the Machine: The Art of Prompt Engineering ✔️ Duncan Changfoot and Moleboheng Madela: Navigating the Intersection of Leadership: How Digital Transformation Altered My Perspective 💬 Join the panel discussion led by Eric Harvey and Faheeza Rangunwala on "The Efficiency Journey" to dive deeper into topics on digital transformation, automation, and open-source trends. Don’t miss out—ask your questions or connect with our experts! 🔗 Explore the full agenda here and message us if you’d like a copy of the slides: https://lnkd.in/gAgq8jZu #PHUSE #DigitalTransformation #Automation #OpenSource #PromptEngineering #Biometrics #OneMMS #DataScience #SouthAfrica

MMS is thrilled to share this outstanding feedback from the Head of Biometrics at an EU-based pharmaceutical company! It’s not often that people say you’re “one of the best,” and such recognition speaks volumes about the dedication, expertise, and professionalism of our team. This type of feedback is better than any industry award, because it comes from the heart. ❤️ Faced with an urgent delivery and little margin for error, the comprehensive biometrics experts at MMS took on the challenge with precision and excellence. If you need biometrics support, connect with us here: https://hubs.li/Q02M00qm0 #SponsorsSay #Biometrics #OneMMS

During Session 8 of DIA's upcoming Global Clinical Trial Disclosure and Data Transparency Conference, our very own Raina Agarwal will be presenting on “Accelerating Clinical Trials Publication by Proactively Protecting CCI: Adapting to EU-CTIS Revised Transparency Rules!” Raina, Associate Director of Clinical Trial Disclosure and Transparency, will be joined by session chair Scott Feiner, Senior Manager of Trial Disclosure at AbbVie, and fellow thought leader Dr. Marianne Lunzer, Assessor in the Department of Clinical Trials, Federal Office for Safety in Health Care at AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit, Austria. Learn about the latest requirements in clinical trial disclosure and data transparency, and engage in in-depth discussions at the event. Register and join us: https://hubs.li/Q02LSw9p0 #CCI #CTIS #ClinicalTrialTransparency

At a recent event in Amsterdam, our full-spectrum biometrics solutions team observed that Bayesian methodology in efficacy analyses is quickly emerging in the pharmaceutical industry. A presentation by a member of the EMA methods working group highlighted key perspectives on using Bayesian methods for sensitivity and confirmatory purposes. However, utilizing Bayesian methodology for Primary Endpoints may present challenges if frequentist alternatives exist. Early communication with the EMA is crucial to ensure the methodology is 'fit-for-purpose.' At MMS, our biostatisticians leverage in-house expertise to guide Sponsors through Bayesian assessments while exploring other effective alternatives. Read more perspectives from the event here: https://hubs.li/Q02LH6Nj0 #ClinicalResearch #BayesianMethodology #EMA #Biostatistics #Biometrics #OneMMS

We’re just 1 week away from our highly anticipated PHUSE Single Day Event (SDE) in Bloemfontein, titled "The Efficiency Journey: Digital Transformation, Automation, and Open Source!" This is your chance to dive into the latest advancements, engage with biometrics experts and professionals, and gain the following: ➡️ Insights into digital transformation and its impact ➡️ Strategies for effective automation ➡️ The benefits and challenges of open source Come connect, learn, and share experiences with your peers. We look forward to hosting you! Secure your spot now: https://hubs.li/Q02KY0y20 #PHUSE #Biometrics #Bloemfontein

Today, we join the world in celebrating India’s Independence Day, honoring the spirit of freedom and progress that defines this vibrant country! Since 2007, MMS has held a significant presence across India, including Bangalore and Hyderabad. Our teams in India contribute immensely to our global success, bringing innovation, expertise, and dedication to every project. Let’s recognize and celebrate the incredible talent and hard work of our colleagues in India. Wishing everyone a Happy Independence Day! #IndependenceDay #India #Bangalore #Hyderabad #OneMMS

Selecting the right site is crucial for clinical trial success! Our proprietary tool, Datacise®, streamlines this process with its advanced geospatial visualization capabilities, including: ✅ Customizable Layers: Combine race, disease prevalence, and more to find the perfect site. ✅ Drive Time Analysis: Assess accessibility and ensure participants are within a reasonable commute. ✅ Disease Prevalence: Layer disease data to match sites with trial needs. Fast implementation, easy access, and a higher level of customization to your specific study requirements come standard with Datacise. Learn more about our approach to geospatial visualization here: https://hubs.li/Q02Lf1SP0 #ClinicalTrials #Pharma #DataScience #DataVisualization #DrugDevelopment

Imagine the gratitude felt by our biometrics and regulatory affairs experts upon receiving this glowing review! At MMS, our willingness to tackle any challenge with remarkable efficiency and minimal pushback is the “norm.” This is driven by our guiding principle to operate with a Sense of Urgency & Leadership (SOUL). Thank you to our amazing team and our valued clients for your continued trust and support! What has your experience been like working with, or at, MMS? Leave a comment and let us know! ⬇️ #ClinicalResearch #Biometrics #RegulatoryAffairs #SponsorsSay #OneMMS